Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031180419Completed
Open-label, single-arm trial of letrozole in breast cancer and infertility. Primary endpoints: Rate of recurrence and Birth abnormality. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031180419.